User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

8046

Interactions with Platform & by Email *

INTERACTIONS

1126

Unique # Participated *

PARTICIPANTS

241

Responses Validated *

VALIDATIONS

46

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Remote Patient Monitoring (RPM) – A Transformation Model for Health Care
  Delivery.....II-1
1$100
   Benefits for Patients, Physicians, & Payer.....II-2
Improved Patient Outcomes and Promoting Self-Care.....II-2
Resource Optimization and Savings – A Key Benefit.....II-2
1$100
   Payer Benefits.....II-3
Peek into Key Market Growth Drivers.....II-3
1$100
   Focus on Healthcare Economics Grows as Healthcare Expenditures Rise Globally.....II-4 1$100
   Table 1: Global Healthcare Spending (in US$ Trillion): 2013-2018 (includes corresponding Graph/Chart).....II-51$350
   Table 2: Healthcare Expenditure as a % of GDP Across Select Countries (includes corresponding Graph/Chart).....II-61$350
   Table 3: Elderly Healthcare Expenditure as a % of GDP (includes corresponding Graph/Chart).....II-7
Aging Population Creates High Demand.....II-7
1$350
   Table 4: Ageing (65+) Demographics as % of Total Population by Country (2000, 2011, 2020) (includes corresponding Graph/Chart).....II-8
Chronic Disease Management Presents Huge Market Opportunity.....II-8
1$350
   Table 5: World Market for Telehealth: Patient Distribution (in %) by Disease Condition (includes corresponding Graph/Chart).....II-91$350
   Table 6: Chronic Disease Management in Developed Countries (2014): Percentage Distribution of Patient Population by Chronic Disease Type in the US, Germany, and the UK (includes corresponding Graph/Chart).....II-10
Readmission Penalty on Hospitals Provides Impetus to RPM.....II-10
1$350
   Patient Non-Adherence to Prescribed Medication Promotes RPM Market.....II-11
Table 7: Medication Adherence Rates in the US by Condition (2012) (includes corresponding Graph/Chart).....II-11
1$350
   Wearable Devices Help Boost RPM Adoption.....II-121$100
   Venture Capitalists Keen to Fund RPM Technology Companies.....II-13 1$100
   Table 8: Digital Health Venture Funding in the US (2011-2014) (includes corresponding Graph/Chart).....II-14

Table 9: US Digital Health Venture Capital Funding by Category (in %): 2014 (includes corresponding Graph/Chart).....II-14
1$350
   Market Issues and Challenges.....II-15
High Cost of Remote Patient Monitoring Systems.....II-15
Lack of Reimbursement.....II-15
Patient Privacy Concerns.....II-15
1$100
   Small Practices Challenged by Remote Monitoring Programs.....II-16
Security Issues of Medical Devices.....II-16
1$100
   Competitor Landscape.....II-17
Table 10: Leading Players in the Global Remote Patient Monitoring Market: Percentage Breakdown of Market Share for Boston Scientific, GE Healthcare, Medtronic, Philips Healthcare, St. Jude Medical, and Others (includes corresponding Graph/Chart).....II-17
1$350
   Big Data Management Crucial for Effective RPM.....II-18
Internet of Things (IoT) – Crucial for Healthcare.....II-18
1$100
   Cloud Computing: Enhancing RPM Adoption.....II-191$100
   Partnerships Leverage on Mutual Expertise.....II-201$100
   Will mHealth make Conventional RPM Obsolete?.....II-211$100
   Wireless Consumer Devices Favored Over Telehealth.....II-22
Immobile Patients to Gain from Increased Uptake of Remote Monitoring Devices.....II-22
1$100
   CVD Continues to Grab Focus for Remote Monitoring.....II-23 1$100
   Table 11: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart).....II-24

Table 12: Economic Burden of Cardiovascular Diseases between 2011 and 2015: Breakdown of Lost Output Value by Income Group (includes corresponding Graph/Chart).....II-24
1$350
   Remote Monitoring – New Standard of Care for Patients with CIEDs.....II-251$100
   RPM to Reduce Costs Associated with Diabetes Management.....II-26 1$100
   Table 13: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart).....II-271$350
   Table 14: Top Ten Countries Worldwide with the Highest Number of People (in the Age Group 20-79 Years) with DM (in Millions): 2014E & 2035P (includes corresponding Graph/Chart).....II-28
Remote Monitoring for Neurodegenerative Disease Conditions.....II-28
1$350
   Remote Monitoring of EEG & Treatment Adequacy.....II-291$100
   Remote Monitoring Crucial for COPD and Asthma Management.....II-301$100
   Rising Significance of Remote Blood Pressure Monitoring Benefits Market
  Adoption.....II-31
1$100
   Table 15: Death Rates Due to Hypertension in Select Countries: 2012 (includes corresponding Graph/Chart).....II-321$350
   Table 16: Percentage Prevalence Rate of High Blood Pressure for Patients over 25 Years of Age by Region (1980 and 2013) - Africa, America, South East Asia, Europe, Eastern Mediterranean, and Western Pacific (includes corresponding Graph/Chart).....II-33
Remote Patient Monitoring for Sleep Apnea.....II-33
1$350
   Table 17: Percentage Prevalence of Sleep Apnea in Co-Morbidities by Type of Co-Morbidity (includes corresponding Graph/Chart).....II-341$350
   Introduction.....II-35
Remote Patient Monitoring vs. Telehealth.....II-35
1$100
   Current Monitoring Systems - A Systematic Review.....II-36
Remote Patient Monitoring - Architecture.....II-36
2$200
   Benefits & Challenges of Remote Patient Monitoring Systems.....II-381$100
   Omron Healthcare Launches BP Monitor.....II-39
ALR Technologies Seeks FDA Approval for New Health-e-Connect Feature.....II-39
HTC Launches Monitoring Device HTC Grip.....II-39
Covidien Receives CE Marking for Nellcor System.....II-39
Intel-GE Launches Branded Health Harmony RPM Service.....II-39
Dexcom Receives FDA Approval for Dexcom SHARE Device.....II-39
Honeywell Unveils New Version of Genesis DM™.....II-39
1$100
   Honeywell Unveils Latest Version of LifeStream™.....II-40
AMD Introduces Live Streaming Ultrasound Technology.....II-40
Vital Connect Receives FDA Clearance for HealthPatch™ Biosensor.....II-40
OSTAR Healthcare Launches Remote Patient Monitoring System in North America.....II-40
Masimo’s Radius-7 Wearable Monitor Receives CE Approval.....II-40
CardioMEMS System Receives FDA Approval.....II-40
ReliantHeart’s Assist5® Ventricular Assist Device Receives CE Certification.....II-40
1$100
   HealthInterlink Receives 510(k) clearance for Beacon version 2.0.....II-41
Verizon Receives FDA Clearance for Patient Engagement Tool.....II-41
Sensiotec Unveils Version 2.0 of Virtual Medical Assistant®.....II-41
InfoBionic Receives CE Certification for MoMe™ System.....II-41
Baxter Receives CE Marking for VIVIA Hemodialysis System.....II-41
Verizon Launches Remote Patient Monitoring Platform.....II-41
Preventice Receives CE Certification for BodyGuardian® Monitoring System.....II-41
1$100
   Sorin’s Smartview System Receives FDA Approval.....II-42
Healthx Launches Remote Patient Monitoring Platform.....II-42
Tactio Health Group Launches TactioDiabetes.....II-42
FDA Approves RP-VITA By iRobot Corp. & InTouch Health.....II-42
1$100
   Integrity Applications Enters Distribution Agreements with Chinese Players.....II-43
Roche and Qualcomm Enter Collaboration.....II-43
Honeywell Life Care and MobileHelp Expand Collaboration.....II-43
Honeywell HomMed Changes Name to Honeywell Life Care.....II-43
Welch Allyn Acquires HealthInterLink.....II-43
LabCorp and Envision Healthcare Invest in Vivify Health.....II-43
1$100
   Vital Connect Enters Partnership with LifeWatch.....II-44
Aerocrine Collaborates with Microsoft.....II-44
Preventice and eCardio Diagnostics Enter Strategic Partnership.....II-44
Geneia Acquires Select Rights on ZephyrLIFE From Covidien.....II-44
Healthsense Raises Funding for Remote Patient Monitoring System.....II-44
Maxis Bhd and EWL Announce Partnership for Health Monitoring M2M Solution.....II-44
eCardio Signs Agreement with Shandong Yocaly.....II-44
1$100
   Medtronic Acquires Cardiocom.....II-45
CardioNet Enters Agreement with IMEC & Holst Centre.....II-45
1$100
   Abbott Laboratories (US).....II-46
Aerotel Medical Systems (Israel).....II-46
1$100
   AMD Global Telemedicine, Inc. (US).....II-47
BIOTRONIK SE & Co. KG (Germany).....II-47
Boston Scientific Corporation (US).....II-47
1$100
   GE Healthcare Ltd. (UK).....II-48
Honeywell Life Care Solutions (US).....II-48
1$100
   Intelesens Ltd. (UK).....II-49
LifeWatch AG (Switzerland).....II-49
1$100
   Masimo Corporation (US).....II-50
Medtronic Plc (Ireland).....II-50
1$100
   Mindray North America (US).....II-51
Nihon Kohden Corporation (Japan).....II-51
Omron Healthcare, Inc. (US).....II-51
1$100
   Philips Healthcare (Netherlands).....II-52
Qualcomm Life, Inc. (US).....II-52
1$100
   St. Jude Medical Inc. (US).....II-53
Welch Allyn, Inc. (US).....II-53
1$100
   Table 18: World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-541$350
   Table 19: World Historic Review for Remote Patient Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-551$350
   Table 20: World 14-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-561$350
   A. Market Analysis.....III-1
Key Drivers to Remote Patient Monitoring Market.....III-1
Remote Monitoring Boosted by HRRP.....III-1
1$75
   High Life Expectancy Presents Strong Need for RPM.....III-2
Table 21: Population of the US (2010, 2030 & 2050): Percentage Breakdown by Age Groups - Under 18, 18-64 years & 65+ years (includes corresponding Graph/Chart).....III-2
US – The Leading Market for Remote Cardiac Monitoring.....III-2
1$200
   Table 22: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart).....III-3

Table 23: CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart).....III-3

Table 24: Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart).....III-3
1$200
   Chronic Disease Management – Focus Area for Remote Monitoring.....III-4 1$75
   Table 25: US Healthcare Spending (2006-2020) (in US$ Trillion) (includes corresponding Graph/Chart).....III-5

Table 26: US Healthcare Market: Total Annual Expenditure in US$ Billion by Chronic Disorder/Disease (includes corresponding Graph/Chart).....III-5
Diabetes Statistics in the US.....III-5
1$200
   Table 27: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group.....III-6
Sleep Apnea in the US.....III-6
1$200
   Rise in COPD Incidence Drives RPM Adoption.....III-7
Table 28: Chronic Obstructive Pulmonary Disorder (COPD) Incidence in US (2014): COPD Prevalence in Millions by Age Group (includes corresponding Graph/Chart).....III-7
Reimbursement Scenario.....III-7
1$200
   Remote Monitoring Systems with FDA 510(k) Clearance (2014):.....III-8
Product Launches.....III-8
3$225
   Strategic Corporate Developments.....III-112$150
   Key Players.....III-135$375
   B. Market Analytics.....III-18
Table 29: US Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-18

Table 30: US Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-18
1$200
   A. Market Analysis.....III-19
Product Launch.....III-19
1$75
   B. Market Analytics.....III-20
Table 31: Canadian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-20
1$200
   Table 32: Canadian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-211$200
   A. Market Analysis.....III-22
Graying Population Spurs Growth of Patient Monitoring Equipment.....III-22
Table 33: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-22
Key Player - Nihon Kohden Corporation.....III-22
1$200
   B. Market Analytics.....III-23
Table 34: Japanese Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-23
1$200
   Table 35: Japanese Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-241$200
   A. Market Analysis.....III-25
Prevalence of Diabetes in Europe: Market Opportunity for CGM Devices.....III-25
1$75
   B. Market Analytics.....III-26
Table 36: European Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-26
1$200
   Table 37: European Historic Review for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-271$200
   Table 38: European 14-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-281$200
   Market Analysis.....III-29
Table 39: French Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-29
1$200
   Table 40: French Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-301$200
   A. Market Analysis.....III-31
Key Player - Biotronik SE & Co. KG.....III-31
1$75
   B. Market Analytics.....III-32
Table 41: German Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-32
1$200
   Table 42: German Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Product Launch.....III-34
B. Market Analytics.....III-34
Table 43: Italian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   Table 44: Italian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-351$200
   A. Market Analysis.....III-36
Telecare and Elderly Population Requirements – An Overview.....III-36
1$75
   Self-Monitoring Blood Glucose Meters Gain Popularity.....III-37
Product Approval.....III-37
Key Players.....III-37
2$150
   B. Market Analytics.....III-39
Table 45: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-39
1$200
   Table 46: UK Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-401$200
   Market Analysis.....III-41
Table 47: Spanish Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-41
1$200
   Table 48: Spanish Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-421$200
   Market Analysis.....III-43
Table 49: Russian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-43
1$200
   Table 50: Russian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Strategic Corporate Developments.....III-45
Key Players.....III-45
2$150
   B. Market Analytics.....III-47
Table 51: Rest of European Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-47
1$200
   Table 52: Rest of European Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-481$200
   A. Market Analysis.....III-49
Outlook.....III-49
Improving Infrastructure Facilitates RPM Adoption.....III-49
Undiagnosed Diabetic Population Offers Potential for Remote Monitoring.....III-49
1$75
   B. Market Analytics.....III-50
Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-50
1$200
   Table 54: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-511$200
   Table 55: Asia-Pacific 14-Year Perspective for Remote Patient Monitoring Systems by Region - Percentage Breakdown of Value Sales for China and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-521$200
   A. Market Analysis.....III-53
Large Population Results in Quicker RPM Adoption.....III-53
1$75
   Table 56: Healthcare Expenditure in China as a % of GDP (2006-2015) (includes corresponding Graph/Chart).....III-54

Table 57: Percentage of Population Aged 65 and Above in China (2000-2020) (includes corresponding Graph/Chart).....III-54

Table 58: Incidence of Chronic Diseases in China (2014) (includes corresponding Graph/Chart).....III-54
1$200
   China: An Untapped Goldmine for Blood Glucose Monitoring Devices.....III-55
Strategic Corporate Development.....III-55
1$75
   B. Market Analytics.....III-56
Table 59: Chinese Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-56

Table 60: Chinese Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-56
1$200
   A. Market Analysis.....III-57
India: Remote Patient Monitoring Gains Popularity.....III-57
Rising Diabetic Populace Spurs Growth in Remote Glucose Monitoring Devices.....III-57
1$75
   Strategic Corporate Development.....III-581$75
   B. Market Analytics.....III-59
Table 61: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-59
1$200
   Table 62: Rest of Asia-Pacific Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-601$200
   Market Analysis.....III-61
Table 63: Latin American Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-61
1$200
   Table 64: Latin American Historic Review for Remote Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-621$200
   Table 65: Latin American 14-Year Perspective for Remote Patient Monitoring Systems by Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-631$200
   Market Analysis.....III-64
Table 66: Brazilian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-64
1$200
   Table 67: Brazilian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-651$200
   Market Analysis.....III-66
Table 68: Rest of Latin American Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-66
1$200
   Table 69: Rest of Latin American Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-671$200
   A. Market Analysis.....III-68
Key Player - Aerotel Medical Systems (Israel).....III-68
1$75
   B. Market Analytics.....III-69
Table 70: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-69
1$200
   Table 71: Rest of World Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-701$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com